Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
21,497,164
-
Share change
-
+13,482,389
-
Total reported value
-
$51,592,000
-
Price per share
-
$2.40
-
Number of holders
-
17
-
Value change
-
+$32,352,603
-
Number of buys
-
9
-
Number of sells
-
6
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q4 2016
As of 31 Dec 2016,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,497,164 shares.
The largest 10 holders included
CAXTON CORP, NEA Management Company, LLC, Vivo Capital, LLC, Broadfin Capital, LLC, RA CAPITAL MANAGEMENT, LLC, Opaleye Management Inc., Boxer Capital, LLC, Tredje AP-fonden, Granite Point Capital Management, L.P., and Anson Funds Management LP.
This page lists
17
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.